This tetraaromatic compound is a weak agonist that induces S1P1 internalization but then allows, similar to S1P, receptor recycling instead of receptor degradation, which translates into rapidly reversible lymphopenia [28]. The gene discussed is S1PR1; the disease is lymphopenia.